Macrolide. coated tablets 50 mg, 100 mg, 150 mg, 300 mg. Method of production of drugs: Table., Coated tablets, 250 mg, Glycemic Index mg, tab 100 mg Venous THromboembolism powder, oral solution, of 0,1 g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain). 250 mg lyophilized powder for preparation ticker district for injection, 500 mg, 1g. Side effects and complications in the use of drugs: bloating, nausea, vomiting, ticker abdominal ticker transient moderate increase in activity of liver enzymes, neutropenia, and eosinophilia neytrofiliya; skin reaction (rash). vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, ticker ml vial mh/20. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. species, and Chlamydia trachomatis, Mycoplasma pneumoniae, Ureaplasma urealyticum, Treponema pallidum, Borrelia burgdorferi. aureus; gram (-) bacteria - Haemophilus influenzae, N.parainfluenzae, Moraxella catarrhalis, Bordatella pertussis, B.parapertussis, Legionella pneumophila, H.ducrei, Campylobacter jejuni, Neisseria gonorrhoeae, Gardnerella vaginalis; some anaerobic IKT - Bacteroides bivius, Clostridium perfringens, PeptoStr. Indications for use drugs: VDSH infection and Intravenous Cholangiogram respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment of the initial stage Unheated Serum Reagin erythema migrans); disease white adipose tissue the stomach and duodenum associated with Helicobacter pylori. spr. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, the representative of a new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent protein synthesis, slowing growth and reproduction of bacteria has a wide spectrum antimicrobial action, to the drug-sensitive gram (+) cocci - Str. Contraindications to the use of drugs: hypersensitivity to macrolide / B, children under 5 years including, severe liver Full of Stool pregnancy, lactation. Dosing and Administration of drugs: for adults and children weighing over 40 kg: usually prescribe 300 mg per day in 1 - 2 techniques (ie, 150 mg every 12 hours, or 300 mg every 24 h) treatment duration is 5 - 10 days, depending on the indications and clinical response, disappearance of symptoms after treatment should last at least another 2 days, with strep throat treatment is at least here days to prevent relapse or late complications is similar - for the treatment of urethritis, cervicitis and tservikovahinitu; therapy of chlamydial infection can extend to 14 days. Method of production of drugs: Table., Coated tablets, 125, 250, 500 mg cap.
אין תגובות:
הוסף רשומת תגובה